Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis
Clinical trial NCT04115293 · COMPLETED
Trial details
- NCT number
- NCT04115293
- Sponsor
- Ra Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-17
- Primary completion
- 2021-12-30
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.